STOK STOKE THERAPEUTICS INC Management Changes 8-K Filing 2023 - Appointment of Director Stoke Therapeutics, Inc. elected Ian F. Smith as a Class II director, who will receive an annual cash retainer and stock options as part of his compensation.Get access to all SEC 8-K filings of the STOKE THERAPEUTICS INC